StockData
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX) stock

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.20−0.28 (-3.74%)

Close on Nov 17, 2026Market cap $515.08MP/E –Yield –

Immix Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Immix Biopharma's price to book ratio was 2.7× on Nov 11, 2026, against 13.6× a year earlier. Over the last 5 years it ranged from 0.8× to 23.2×, with a median of 3.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.7×−20.5
2025Oct 31, 202523.2×+19.8
2024Dec 31, 20243.4×−3.4
2023Dec 29, 20236.9×+5.0
2022Dec 30, 20221.9×–

More Immix Biopharma figures

See a number that looks wrong?